Hypericin enhances β-lactam antibiotics activity by inhibiting sarA expression in methicillin-resistant Staphylococcus aureus

Bacteremia is a life-threating syndrome often caused by methicillin-resistant Staphylococcus aureus (MRSA). Thus, there is an urgent need to develop novel approaches to successfully treat this infection. Staphylococcal accessory regulator A (SarA), a global virulence regulator, plays a critical role...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Pharm Sin B
Autors principals: Wang, Genzhu, Li, Liang, Wang, Xiukun, Li, Xue, Zhang, Youwen, Yu, Jie, Jiang, Jiandong, You, Xuefu, Xiong, Yan Q.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900551/
https://ncbi.nlm.nih.gov/pubmed/31867163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.05.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars